120 related articles for article (PubMed ID: 24124110)
1. ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status.
Wiggers TG; Westra G; Westers TM; Abbes AP; Strunk A; Kuiper-Kramer E; Poddighe P; van de Loosdrecht AA; Chamuleau ME
Cytometry B Clin Cytom; 2013 Oct; ():. PubMed ID: 24124110
[TBL] [Abstract][Full Text] [Related]
2. ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status.
Wiggers TG; Westra G; Westers TM; Abbes AP; Strunk A; Kuiper-Kramer E; Poddighe P; van de Loosdrecht AA; Chamuleau ME
Cytometry B Clin Cytom; 2014 Jul; 86(4):280-7. PubMed ID: 24924909
[TBL] [Abstract][Full Text] [Related]
3. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia.
Stamatopoulos B; Meuleman N; Haibe-Kains B; Duvillier H; Massy M; Martiat P; Bron D; Lagneaux L
Clin Chem; 2007 Oct; 53(10):1757-66. PubMed ID: 17702857
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
van't Veer MB; Brooijmans AM; Langerak AW; Verhaaf B; Goudswaard CS; Graveland WJ; van Lom K; Valk PJ
Haematologica; 2006 Jan; 91(1):56-63. PubMed ID: 16434371
[TBL] [Abstract][Full Text] [Related]
5. B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens.
Sabattini E; Orduz R; Campidelli C; Zinzani PL; Callea V; Zupo S; Cutrona G; Morabito F; Ferrarini M; Pileri S
J Clin Pathol; 2007 Jun; 60(6):627-32. PubMed ID: 16916999
[TBL] [Abstract][Full Text] [Related]
6. COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Plesingerova H; Librova Z; Plevova K; Libra A; Tichy B; Skuhrova Francova H; Vrbacky F; Smolej L; Mayer J; Bryja V; Doubek M; Pospisilova S
Leuk Lymphoma; 2017 Jan; 58(1):70-79. PubMed ID: 27185377
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.
MacIntyre DA; Jiménez B; Lewintre EJ; Martín CR; Schäfer H; Ballesteros CG; Mayans JR; Spraul M; García-Conde J; Pineda-Lucena A
Leukemia; 2010 Apr; 24(4):788-97. PubMed ID: 20090781
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression.
Admirand JH; Knoblock RJ; Coombes KR; Tam C; Schlette EJ; Wierda WG; Ferrajoli A; O'Brien S; Keating MJ; Luthra R; Medeiros LJ; Abruzzo LV
Mod Pathol; 2010 Nov; 23(11):1518-23. PubMed ID: 20657554
[TBL] [Abstract][Full Text] [Related]
10. Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.
Pede V; Rombout A; Vermeire J; Naessens E; Vanderstraeten H; Philippé J; Verhasselt B
Br J Haematol; 2013 Dec; 163(5):621-30. PubMed ID: 24219331
[TBL] [Abstract][Full Text] [Related]
11. Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance.
López C; Delgado J; Costa D; Villamor N; Navarro A; Cazorla M; Gómez C; Arias A; Muñoz C; Cabezas S; Baumann T; Rozman M; Aymerich M; Colomer D; Pereira A; Cobo F; López-Guillermo A; Campo E; Carrió A
Genes Chromosomes Cancer; 2013 Oct; 52(10):920-7. PubMed ID: 23893575
[TBL] [Abstract][Full Text] [Related]
12. T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cells.
Rizzo D; Bouvier G; Youlyouz-Marfak I; Guerin E; Trimoreau F; Bordessoule D; Jaccard A; Gachard N; Feuillard J
Cytometry B Clin Cytom; 2013 Mar; 84(2):125-32. PubMed ID: 23225571
[TBL] [Abstract][Full Text] [Related]
13. Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.
Morabito F; Cutrona G; Mosca L; D'Anca M; Matis S; Gentile M; Vigna E; Colombo M; Recchia AG; Bossio S; De Stefano L; Maura F; Manzoni M; Ilariucci F; Consoli U; Vincelli I; Musolino C; Cortelezzi A; Molica S; Ferrarini M; Neri A
Leuk Res; 2015 Aug; 39(8):840-5. PubMed ID: 26038121
[TBL] [Abstract][Full Text] [Related]
14. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
15. Prognosis Factors in Chronic Lymphocytic Leukemia.
Ivanescu AM; Oprea M; Momanu R; Coles E; Colita A; Lupu AR
J Med Life; 2012; 5(Spec Issue):48-53. PubMed ID: 31803286
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
Putowski M; Podgórniak M; Piróg M; Knap J; Zaleska J; Purkot J; Zawiślak J; Zakrzewska E; Karczmarczyk A; Własiuk P; Subocz E; Giannopoulos K
Pol Arch Intern Med; 2017 Apr; 127(4):238-244. PubMed ID: 28424451
[TBL] [Abstract][Full Text] [Related]
17. A novel diagnostic biosensor for distinguishing immunoglobulin mutated and unmutated types of chronic lymphocytic leukemia.
Ensafi AA; Amini M; Rezaei B; Talebi M
Biosens Bioelectron; 2016 Mar; 77():409-15. PubMed ID: 26436328
[TBL] [Abstract][Full Text] [Related]
18. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
19. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.
Boonstra JG; van Lom K; Langerak AW; Graveland WJ; Valk PJ; Kraan J; van 't Veer MB; Gratama JW
Cytometry B Clin Cytom; 2006 May; 70(3):136-41. PubMed ID: 16568475
[TBL] [Abstract][Full Text] [Related]
20. ZAP70 expression assessed by immunohistochemistry on peripheral blood: a simple prognostic assay for patients with chronic lymphocytic leukemia.
Roullet M; Sargent R; Pasha T; Cajiao I; Elstrom R; Smith T; Liebhaber S; Zhang P; Bagg A
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):471-6. PubMed ID: 18091393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]